Sunshine Biopharma Inc Ordinary Shares SBFM 深 沪
等待开盘 11-26 09:30:00 美东时间
1.39
0.000
0.00%
华盛通- 最 高1.39
- 今 开1.37
- 成交量 7.01万股
- 最 低 1.34
- 昨 收 1.39
- 总市值 681.92万
- 52周最高 3.90
- 市盈率 静 --
- 换手率 1.43%
- 52周最低 1.1693
- 委 比 -91.09%
- 总股本 490.59万
- 历史最高 19740.00
- 量 比 0.66
- 振 幅 3.60%
- 历史最低 1.1693
- 每 手 1
- 风险率 0.58%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Sunshine Biopharma Stock Is Surging Thursday: Here's What's Happening
Shares of Sunshine Biopharma Inc. (NASDAQ: SBFM) are trading higher Thursday after the Florida-based pharmaceutical company announced the launch of a generic prescription drug.
10-16 22:24
Sunshine Biopharma Canadian Subsidiary, Nora Pharma, Launches Pravastatin, Generic Prescription Drug In Therapeutic Class Of Lipid Metabolism Regulators
Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced that its
10-16 19:55
Sunshine Biopharma approves $5M strategic bitcoin investment
Sunshine Biopharma's (NASDAQ:SBFM) board has approved a $5M investment in Bitcoin as a strategic reserve asset. The investment aligns with the company’s broader strategy to enhance financial strength ...
10-14 19:53
美股大行评级 | 最高186美元！戴尔科技或多家机构上调目标价； 高盛上调超微公司目标价至210美元
今日重点评级关注：富国银行：维持Kyverna Therapeutics"超配"评级，目标价从24美元升至27美元；Chardan Capital：维持Oculis Holding"买入"评级，目标价从33美元升至51美元
10-09 10:51
Aegis Capital Reiterates Buy on Sunshine Biopharma, Maintains $7 Price Target
Aegis Capital analyst David Bouchey reiterates Sunshine Biopharma (NASDAQ:SBFM) with a Buy and maintains $7 price target.
10-09 00:46
Sunshine Biopharma Filed U.S. Patent Application #20250276036 For "COMPOSITION FOR THE INHIBITION OF NRF2 AND USES THEREOF IN CANCER THERAPY"
https://ppubs.uspto.gov/api/pdf/downloadPdf/20250276036?requestToken=eyJzdWIiOiIyZDUxZWIxMy0xNzcwLTRmZDItYWZhYi1hZDZhM2MxMzVjOTQiLCJ2ZXIiOiIzYWZmYTM0My00ODdkLTQ4YTMtOWNmNy05NWFhM2IwOTYzZGMiLCJleHAiOjB9
09-05 04:00
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Scinai Immunotherapeutics (NASDAQ:SCNI) stock rose 24.9% to $3.11 duri...
07-02 20:06
Sunshine Biopharma Announces That Its Wholly Owned Canadian Subsidiary, Nora Pharma, Has Launched Niopeg, The Company's First Biosimilar Drug
Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced that its
07-02 20:06
Sunshine Biopharma's Canadian Subsidiary, Nora Pharma, Launches Gabapentin, A New Generic Prescription Drug In The Therapeutic Class Of Anticonvulsants
Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced that its
06-11 20:56
Sunshine Biopharma reports Q1 results
Sunshine Biopharma press release (NASDAQ:SBFM): Q1 Revenue of $8.9M (+18.0% Y/Y). More on Sunshine Biopharma Seeking Alpha’s Quant Rating on Sunshine Biopharma Historical earnings data for Sunshine Bi...
05-16 16:05
